PM
PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
$1.50 +3.45% (+$0.05)
1M +14.50%
Market Cap $80.0M
P/E Ratio -
Div. Yield -
ROE 78.11%
Bulios Fair Price
$1.63
8.7% upside
Trenutna cena
$1.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PMVP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 1.12x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 24.78%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 111.12%
ROE 78.11%
ROA 91.66%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 7.70x
Int. coverage N/A
Stability
48 /100
Moderate Beta 1.37x
EPS volatility 26.94%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PMVP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David H. Mack
Employees
54
Headquarters
Princeton
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report